Fiveable

🦠Virology Unit 10 Review

QR code for Virology practice questions

10.1 Mechanisms of viral entry and uncoating

🦠Virology
Unit 10 Review

10.1 Mechanisms of viral entry and uncoating

Written by the Fiveable Content Team • Last updated September 2025
Written by the Fiveable Content Team • Last updated September 2025
🦠Virology
Unit & Topic Study Guides

Viruses have evolved clever ways to sneak into our cells. They latch onto specific receptors, hitch a ride through the cell membrane, and then shed their outer layers. It's like a molecular heist, with viruses using our own cellular machinery against us.

Once inside, viruses unpack their genetic cargo, ready to hijack our cells. This process varies between enveloped and non-enveloped viruses, influencing how they spread and survive. Understanding these entry tricks is key to stopping viral invasions.

Viral Entry Mechanisms

Attachment and Receptor Interactions

  • Viral attachment involves specific interactions between viral surface proteins (ligands) and host cell receptors, initiating the entry process
  • Viruses exploit existing cellular uptake pathways (clathrin-mediated endocytosis, caveolin-dependent endocytosis)
  • Some viruses induce macropinocytosis where cell membrane ruffles and engulfs large volumes of extracellular fluid containing viral particles
  • Choice of entry mechanism depends on virus structure, host cell type, and environmental factors
  • Examples of viral ligands include:
    • Hemagglutinin in influenza viruses
    • Spike protein in coronaviruses
  • Host cell receptors examples:
    • ACE2 for SARS-CoV-2
    • CD4 for HIV

Endocytosis and Membrane Fusion

  • Endocytosis internalizes virus within a vesicle, often triggered by receptor binding
  • Membrane fusion utilized by enveloped viruses merges viral envelope with host cell membrane
  • Direct penetration used by some viruses injects genetic material through cell membrane without full internalization
  • Endocytosis pathways include:
    • Clathrin-mediated endocytosis (influenza virus)
    • Caveolin-dependent endocytosis (SV40 virus)
  • Membrane fusion examples:
    • HIV uses gp41 protein for fusion at the cell surface
    • Influenza virus fuses within endosomes after pH-induced conformational changes

Uncoating and Genetic Material Release

Uncoating Process and Mechanisms

  • Uncoating releases viral genome from protective capsid into host cell cytoplasm or nucleus
  • Enveloped viruses begin uncoating with fusion of viral envelope with cellular membranes, exposing nucleocapsid
  • Non-enveloped viruses undergo conformational changes from cellular triggers, leading to capsid destabilization and genome release
  • Endosomal acidification triggers conformational changes in viral proteins, crucial for many uncoating processes
  • Some viruses use host cell proteases to degrade capsid proteins, facilitating genome release
  • Uncoating may occur in stages:
    • Partial disassembly at cell surface or in endosomes
    • Complete genome release in cytoplasm or nucleus

Timing and Cellular Factors

  • Timing and location of uncoating critical for successful viral replication
  • Uncoating process influences host's ability to detect and respond to infection
  • Cellular factors involved in uncoating:
    • pH changes in endosomes (influenza virus)
    • Cellular chaperones (adenovirus)
    • Proteasome activity (reovirus)
  • Examples of uncoating locations:
    • Poliovirus uncoats in the cytoplasm
    • Herpesvirus uncoats at the nuclear pore

Enveloped vs Non-enveloped Entry

Structural Differences and Entry Strategies

  • Enveloped viruses possess lipid bilayer from host cell membranes, non-enveloped viruses lack outer membrane
  • Enveloped viruses enter through membrane fusion at cell surface or within endosomes, using viral fusion proteins
  • Non-enveloped viruses enter through endocytosis followed by membrane penetration or pore formation in endosomal membrane
  • Enveloped viruses exploit cellular membrane fusion machinery
  • Non-enveloped viruses rely on capsid protein conformational changes for entry
  • Examples of enveloped viruses:
    • Influenza virus
    • HIV
    • Coronavirus
  • Examples of non-enveloped viruses:
    • Adenovirus
    • Poliovirus
    • Rotavirus

Uncoating and Environmental Stability

  • Enveloped virus uncoating begins with envelope fusion
  • Non-enveloped viruses require more extensive capsid disassembly for uncoating
  • Enveloped viruses more susceptible to environmental factors and disinfectants due to lipid envelope
  • Non-enveloped viruses tend to be more stable in various environments
  • Both types can use receptor-mediated endocytosis, but subsequent steps in cell entry and uncoating differ significantly
  • Environmental stability examples:
    • Influenza virus (enveloped) survives on surfaces for hours
    • Norovirus (non-enveloped) can persist for weeks on surfaces

Host Cell Receptors and Tropism

Receptor Function and Viral Tropism

  • Host cell receptors are specific molecules on cell surface that viruses recognize and bind to, initiating entry process
  • Distribution and abundance of specific receptors on different cell types determine viral tropism, influencing infectable tissues
  • Receptor binding often triggers conformational changes in viral proteins, facilitating subsequent entry steps
  • Some viruses use multiple receptors or co-receptors, affecting ability to infect different cell types or species
  • Affinity and specificity of virus-receptor interactions influence efficiency of viral entry and overall infection course
  • Examples of receptor-mediated tropism:
    • HIV targets CD4+ T cells using CD4 and chemokine receptors
    • Hepatitis B virus targets liver cells using sodium taurocholate cotransporting polypeptide (NTCP)

Evolutionary Aspects and Therapeutic Implications

  • Evolutionary changes in viral surface proteins can alter receptor usage, potentially changing host range or tissue tropism
  • Understanding virus-receptor interactions crucial for developing antiviral strategies (entry inhibitors, receptor decoys)
  • Receptor binding sites often conserved, making them potential targets for broad-spectrum antivirals
  • Examples of receptor-based antiviral strategies:
    • Maraviroc blocks HIV entry by targeting CCR5 co-receptor
    • Neutralizing antibodies against viral attachment proteins (influenza hemagglutinin)